Pure Global

saypha filler Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic - ARTG 475369

Access comprehensive regulatory information for saypha filler Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 475369 and sponsored by AA-Med Pty Ltd, manufactured by Croma-Pharma GmbH in Austria. The device registration started on January 08, 2025.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class III
ARTG 475369
Class III
saypha filler Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
ARTG ID: 475369
Good Name: AA-Med Pty Ltd - saypha filler Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

The intended aesthetic purpose of saypha filler Lidocaine is to add volume. It is indicated to correct moderate to severe nasolabial folds and for lip augmentation, and must be injected injected into the mid to deep dermis or submucosa.

Device Classification
Risk Class
Class III
Product Type
Procedure Pack
ARTG Category
General
Registration Information
ARTG ID
475369
Start Date
January 08, 2025
Effective Date
January 08, 2025
Sponsor
Manufacturer
Country
Austria
Address
Industriezeile 6, Leobendorf, 2100